Conduritol B epoxide

CAS No. 6090-95-5

Conduritol B epoxide( —— )

Catalog No. M24607 CAS No. 6090-95-5

Conduritol B epoxide is an irreversible inhibitor of β-glucosidase (GCase).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 37 In Stock
10MG 72 In Stock
25MG 95 In Stock
50MG 157 In Stock
100MG 233 In Stock
200MG 349 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Conduritol B epoxide
  • Note
    Research use only, not for human use.
  • Brief Description
    Conduritol B epoxide is an irreversible inhibitor of β-glucosidase (GCase).
  • Description
    Conduritol B epoxide is an irreversible inhibitor of β-glucosidase (GCase).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    Glucokinase
  • Recptor
    α-glucosidase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    6090-95-5
  • Formula Weight
    162.1
  • Molecular Formula
    C6H8O5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:50 mg/mL (308.38 mM; Need ultrasonic);Water:20 mg/mL (123.35 mM)
  • SMILES
    OC(C1OC1C(C1O)O)C1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Liou B, et al. Modulating ryanodine receptors with dantrolene attenuates neuronopathic phenotype in Gaucher disease mice. Hum Mol Genet. 2016 Sep 20. pii: ddw322. [Epub ahead of print]
molnova catalog
related products
  • POMHEX

    Pomhex, a cell-permeable potent enolase inhibitor with anticancer activity, is used in the study of cancer lethality.Pomhex, a racemic mixture, is a potent and selective ENO2 inhibitor.

  • Tryptophan N-indol-3...

    Indole-3-acetyl-L-tryptophan is involved in regulatory mechanisms for the control of auxin activity during physiological and pathophysiological responses. It may also be used in the synthesis of β-D-galactosidase and β-D-glucosidase inhibitors.

  • MK-0941

    MK-0941 (MK0941) is a novel potent, orally active Glucokinase (GK) activator with EC50 of 0.240 and 0.065 uM in 2.5 and 10 mM glucose, respectively.